| Estrogen as a key regulator of energy homeostasis and metabolic health F Mahboobifard, MH Pourgholami, M Jorjani, L Dargahi, M Amiri, ... Biomedicine & Pharmacotherapy 156, 113808, 2022 | 47 | 2022 |
| Attenuation of morphine tolerance and dependence by thymoquinone in mice H Hosseinzadeh, S Parvardeh, A Masoudi, M Moghimi, F Mahboobifard Avicenna Journal of Phytomedicine 6 (1), 55, 2016 | 33 | 2016 |
| The prevalence of polycystic ovary syndrome, its phenotypes and cardio-metabolic features in a community sample of Iranian population: Tehran lipid and glucose study M Farhadi-Azar, S Behboudi-Gandevani, M Rahmati, F Mahboobifard, ... Frontiers in Endocrinology 13, 825528, 2022 | 23 | 2022 |
| The role of ERα36 in cell type-specific functions of estrogen and cancer development F Mahboobifard, L Dargahi, M Jorjani, FR Tehrani, MH Pourgholami Pharmacological Research 163, 105307, 2021 | 23 | 2021 |
| Role of L-arginine/NO/cGMP/KATP channel signaling pathway in the central and peripheral antinociceptive effect of thymoquinone in rats S Parvardeh, M Sabetkasaei, M Moghimi, A Masoudi, S Ghafghazi, ... Iranian Journal of Basic Medical Sciences 21 (6), 625, 2018 | 22 | 2018 |
| Age-specific cut-off levels of anti-Müllerian hormone can be used as diagnostic markers for polycystic ovary syndrome F Ramezani Tehrani, M Rahmati, F Mahboobifard, F Firouzi, N Hashemi, ... Reproductive Biology and Endocrinology 19 (1), 76, 2021 | 19 | 2021 |
| Expression patterns of ERα66 and its novel variant isoform ERα36 in lactotroph pituitary adenomas and associations with clinicopathological characteristics F Mahboobifard, F Bidari-Zerehpoosh, Z Davoudi, M Panahi, L Dargahi, ... Pituitary 23, 232-245, 2020 | 17 | 2020 |
| Prevalence of idiopathic hirsutism: A systematic review and meta‐analysis M Amiri, A Fallahzadeh, A Sheidaei, F Mahboobifard, ... Journal of Cosmetic Dermatology 21 (4), 1419-1427, 2022 | 13 | 2022 |
| To what extent does polycystic ovary syndrome influence the cut-off value of prolactin? Findings of a community-based study F Mahboobifard, M Rahmati, M Amiri, F Azizi, FR Tehrani Advances in Medical Sciences 67 (1), 79-86, 2022 | 9 | 2022 |
| Is there any association between migraine headache and polycystic ovary syndrome (PCOS)? A review article N Sarahian, M Noroozzadeh, M Saei Ghare Naz, ... Molecular biology reports, 1-9, 2022 | 9 | 2022 |
| Effects of Rosa damascena on reproductive improvement, metabolic parameters, liver function and insulin-like growth factor-1 gene expression in estradiol valerate induced … M Farhadi-Azar, M Ghahremani, F Mahboobifard, M Noroozzadeh, ... biomedical journal 46 (3), 100538, 2023 | 6 | 2023 |
| A meta-analysis of observational studies on prolactin levels in women with polycystic ovary syndrome M Saei Ghare Naz, M Mousavi, F Mahboobifard, A Niknam, ... Diagnostics 12 (12), 2924, 2022 | 6 | 2022 |
| The effects of different physiologic concentrations of prolactin in association with reproductive hormones on the incidence of type 2 diabetes mellitus in men: Tehran Lipid and … A Niknam, F Mahboobifard, M Rahmati, F Firouzi, E Rojhani, F Azizi, ... BMC Endocrine Disorders 22 (1), 302, 2022 | 3 | 2022 |
| Impact of polycystic ovary syndrome on silent coronary artery disease and cardiovascular events; a long-term population-based cohort study F Mahboobifard, M Rahmati, A Niknam, E Rojhani, AA Momenan, F Azizi, ... Archives of Medical Research 53 (3), 312-322, 2022 | 3 | 2022 |
| Anti-Mullerian hormone and cardiometabolic status: a systematic review A Fallahzadeh, F Ramezeni Tehrani, M Rezaee, F Mahboobifard, M Amiri Biomarkers 28 (6), 486-501, 2023 | 2 | 2023 |
| A single cut-off value of anti-Müllerian hormone should not be used for the diagnosis of PCOS in all reproductive-aged women F Mahboobifard, M Rahmati, F Ramezani Tehrani Human Reproduction 37 (3), 621-622, 2022 | 1 | 2022 |
| Astaxanthin as a potent neuroprotective agent F Mahboobifard, M Jorjani Pajoohandeh Journal 22 (6), 336-345, 2017 | | 2017 |
